Research programme: granulocyte colony-stimulating factor - SkyePharma
Alternative Names: GCSF-SkyePharma; Granulocyte colony-stimulating factor - SkyePharmaLatest Information Update: 20 Oct 2005
At a glance
- Originator SkyePharma PLC
- Class
- Mechanism of Action Granulocyte colony stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neutropenia
Most Recent Events
- 20 Oct 2005 Preclinical trials in Neutropenia in United Kingdom (unspecified route)